杜斌，1968年生，籍贯重庆市，中国医学科学院北京协和医院（临床医学研究所）副院（所）长，重症医学教授，主任医师，博士生导师。1986-1994年在中国协和医科大学医学专业攻读医学博士学位，毕业后从事重症医学临床工作及临床医学研究。2000年晋升为副主任医师。2004年晋升为主任医师。

从事重症医学临床工作近30年，以脓毒症为主要研究方向，在国际上首次系统报告了中国脓毒症的流行病学现状，对二代测序技术用于病原学诊断进行了综合评价，并通过限制三代头孢菌素使用，使脓毒症患者的病死率从36%下降到19%。曾受邀作为首位中国专家参与制定了2021年国际脓毒症临床指南。

全国十大赌博官网

1. Yan Chen, Xu-dong Ma, Xiao-hui Kang, Si-fa Gao, Jin-min Peng, Shan Li, Da-wei Liu, Xiang Zhou, Li Weng, Bin Du* on behalf of China National Critical Care Quality Control Center Group. Association of annual hospital septic shock case volume and hospital mortality. Crit Care 2022; 26: 161 (IF 9.097)

2. Bin Du#, Chunting Wang, Mervyn Singer. Learning for the next pandemic: the Wuhan experience of managing critically ill patients. BMJ 2021; 375: e066090 (IF 39.890)

3. Jianfeng Xie, Zhaohui Tong, Xiangdong Guan, Bin Du, Haibo Qiu, Arthur Slutsky. Critical care crisis and some recommendations during the COVID-19 epidemic in China. Intensive Care Med 2020; 46: 837-840 (IF 17.679, C100)

4. Jianfeng Xie, Wenjuan Wu, Shusheng Li, Yu Hu, Ming Hu, Jinxiu Li, Yi Yang, Tingrong Huang, Kun Zheng, Yishan Wang, Hanyujie Kang, Yingzi Huang, Li Jiang, Wei Zhang, Ming Zhong, Ling Sang, Xia Zheng, Chun Pan, Ruiqiang Zheng, Xiyan Li, Zhaohui Tong*, Haibo Qiu*, Bin Du*. Clinical characteristics and outcomes of critically ill patients with novel coronavirus infectious disease (COVID-19) in China: a retrospective multicenter study. Intensive Care Med 2020; 46(10): 1863-1872 (IF 17.679, C100)

5. Wei-jie Guan#, Zheng-yi Ni#, Yu Hu#, Wen-hua Liang#, Chun-quan Ou#, Jian-xing He#, Lei Liu#, Hong Shan#, Chun-liang Lei#, David S.C. Hui#, Bin Du#, Lan-juan Li#, Guang Zeng#, Kow-Yung Yuen#, Ru-chong Chen, Chun-li Tang, Tao Wang, Ping-yan Chen, Jie Xiang, Shi-yue Li, Jin-lin Wang, Zi-jing Liang, Yi-xiang Peng, Li Wei, Yong Liu, Ya-hua Hu, Peng Peng, Jian-ming Wang, Ji-yang Liu, Zhong Chen, Gang Li, Zhi-jiang Zheng, Shao-qin Qiu, Jie Luo, Chang-jiang Ye, Shao-yong Zhu, Nan-shan Zhong for the China Medical Treatment Expert Group for Covid-19. Clinical characteristics of coronavirus disease 2019 in China. N Eng J Med 2020; 382: 1708-1720 (IF 74.699, C100)

6. Zhikang Ye, Rram Rochwerg, Ying Wang, Neill K. Adhikari, Srinivas Murthy, Fran?ois Lamontagne, Robert A. Fowler, Haibo Qiu, Li Wei, Ling Sang, Mark Loeb, Ning Shen, Minhua Huang, Zhaonan Jiang, Yaseen M. Arabi, Luis Enrique Colunga-Lozano, Li Jiang, Younsuck Koh, Dong Liu, Fang Liu, Jason Phua, Aizong Shen, Tianyi Huo, Bin Du*, Suodi Zhai*, Gordon H. Guyatt*. Treatment of patients with nonsevere and severe coronavirus disease 2019: an evidence-based guideline. CMAJ 2020; 192(20): E536-E545 (IF 7.744)

7. Li Weng, Xin-ying Zeng, Peng Yin, Li-jun Wang, Chun-yao Wang, Wei Jiang, Mai-geng Zhou*, Bin Du*, for the China Critical Care Clinicial Trials Group (CCCCTG). Sepsis-related mortality in China: a descriptive analysis. Intensive Care Med 2018; 44:1071-1080 (IF 15.008)

8. Xiaobo Yang, Bin Du*. Does pulse pressure variation predict fluid responsiveness in critically ill patients? A systematic review and meta-analysis. Crit Care 2014 (IF 5.035, C100)

9. Hai-Nv Gao#, Hong-Zhou Lu#, Bin Cao#, Bin Du#, Hong Shang#, Jian-He Gan, Shui-Hua Lu, Yi-Da Yang, Qiang Fang, Yin-Zhong Shen, Xiu-Ming Xi, Qin Gu, Xian-Mei Zhou, Hong-Ping Qu, Zheng Yan, Fang-Ming Li, Wei Zhao, Zhan-Cheng Gao, Guang-Fa Wang, Ling-Xiang Ruan, Wei-Hong Wang, Jun Ye, Hui-Fang Cao, Xing-Wang Li, Wen-Hong Zhang, Xu-Chen Fang, Jian He, Wei-Feng Liang, Juan Xie, Mei Zeng, Xian-Zheng Wu, Jun Li, Qi Xia, Zhao-Chen Jin, Qi Chen, Chao Tang, Zhi-Yong Zhang, Bao-Min Hou, Zhi-Xian Feng, Ji-Fang Sheng, Nan-Shan Zhong, Lan-Juan Li. Clinical findings in 111 cases of Influenza A (H7N9) virus infection. N Engl J Med 2013; 368: 2277-2285 (IF 53.298, C100)

10. Bin Du#, Yun Long, Hongzhong Liu, Dechang Chen, Dawei Liu, Yingchun Xu, Xiuli Xie. Extended-spectrum beta-lactamase-producing-Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcome. Intensive Care Med 2002; 28(12): 1718-1723. (DOI 10.1007/s00134-002-1521-1) (IF 2.041, C100)